Elicio Therapeutics is a Boston biotech developing lymph node targeted cancer immunotherapies, mainly for cancers with mutant KRAS. It last closed at $1.45 on Nov 20, down 3.33% on the day. The next earnings report for ELTX is expected around Thu, Mar 11, 2027, after the close. For the quarter ended Sep 2026, ELTX reported EPS of -$0.30. Over its last 8 reports the stock moved an average of 7.6% the session after earnings.
AI Auto Pilots
Is ELTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ELTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ELTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ELTX · as of the Nov 20 close · updated each morning
Downtrend
The stock is 10% below its 20 day and 20% below its 50 day average. It is 334% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 41). The nearest support is the swing low (Oct 19) at $1.44, and the nearest resistance the Pivot at $1.49.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 12.2%/day
Key levels
$16.0052 week high+1003.4%
$6.30200 day average+334.5%
$2.35100 day average+62.1%
$1.77Swing high (Nov 10)+22.1%
$1.7450 day average+20.0%
$1.5920 day average+9.7%
$1.55Pivot R1+6.9%
$1.49Pivot+2.8%
$1.45Last close
$1.44Swing low (Oct 19)−0.7%
$1.40Pivot S1−3.4%
$1.2552 week low−13.8%
Indicators
RSI (14)
40.74
Middle of its range
Neutral
MACD
-0.09
Above its signal line
Bullish
Stochastic
48.6
Middle of its range
Neutral
ADX (14)
27.2
Trending down
Williams %R
-61.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-71.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.0%
Change over 10 sessions
Bearish
ATR (14)
$0.18
Typical daily range, 12.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 61.3%/day
Key levels
$16.0052 week high+1003.4%
$6.30200 day average+334.5%
$2.35100 day average+62.1%
$1.77Swing high (Nov 10)+22.1%
$1.7450 day average+20.0%
$1.5920 day average+9.7%
$1.55Pivot R1+6.9%
$1.49Pivot+2.8%
$1.45Last close
$1.44Swing low (Oct 19)−0.7%
$1.40Pivot S1−3.4%
$1.2552 week low−13.8%
Indicators
RSI (14)
32.56
Weak, oversold below 30
Neutral
MACD
-1.55
Above its signal line
Bullish
Stochastic
11.2
Near the bottom of its range
Oversold
ADX (14)
24.3
Weak trend
Williams %R
-90.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-92.4
Oversold below −100, overbought above 100
Neutral
Rate of change
−29.3%
Change over 10 sessions
Bearish
ATR (14)
$0.89
Typical daily range, 61.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ELTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ELTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ELTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ELTXHow many large options trades hit ELTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ELTX in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ELTX is in one of them and how their past ELTX trades turned out.
Elicio Therapeutics is a biotechnology company based in Boston, Massachusetts, that is developing cancer immunotherapies. Its lead candidate, ELI-002 7P, is in clinical trials for pancreatic cancer and is also being studied in colorectal cancer. The company's treatments are designed to deliver immune signals to lymph nodes to generate T cell responses against tumors. Its target patients are those with cancers driven by mutant KRAS, a gene mutation found in many solid tumors.